Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamivudine monotherapy versus treatment interruption in HIV-1 patients with M184V mutation and virologic failure
2004-001590-26Phase 2Terminated
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lamivudine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by IRCCS Ospedale San Raffaele. Started Sep 2004; status: terminated.
02
Drugs
lamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-001590-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001590-26.